Citizens lowered the firm’s price target on DocuSign (DOCU) to $86 from $124 and keeps an Outperform rating on the shares. While Citizens would have liked to see Docusign’s total revenue accelerate in Q4 or in the Q1 guidance, the stock is viewed as an attractive opportunity for capital appreciation, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOCU:
- DOCU Earnings: Docusign Stock Finally Gets a Boost after Reporting a Strong Q4 Beat
- DocuSign sees FY27 revenue $3.484B-$3.496B, consensus $3.42B
- DocuSign reports Q4 EPS $1.01, consensus 95c
- DocuSign sees Q1 revenue $822M-$826M, consensus $813.61M
- DocuSign options imply 9.6% move in share price post-earnings
